Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study ID
- NCT06772350
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- examinations — PROCEDUREEcho-Doppler and blood samples
Study Details
Chronic inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are characterized by chronic immune-mediated inflammation primarily affecting the gastrointestinal tract. Venous and arterial thromboembolic events are significant extra-intestinal manifestations of IBD, but their pathogenic mechanisms are not fully understood. IBD patients have double the risk of venous thromboembolism (VTE) compared to the general population, with particularly high risk in pediatric patients, and an increased mortality rate. They also face a higher risk of early atherosclerosis and future cardiovascular events, such as myocardial infarction, ischemic stroke, and peripheral artery disease. The prevalence of thromboembolic events in IBD ranges from 1.3% to 7.7%, with venous events at around 5% and ischemic heart disease, cerebrovascular disease, and peripheral artery disease at 1-2%.
Key Dates
- Start date
- Jun 15, 2025
- Status verified
- Dec 2024
- Primary completion
- Jul 15, 2026
- Completion
- Jun 15, 2036
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: TreatmentExperimental
Primary Outcome Measure
Measuring altered intestinal permeability and increased thrombotic risk [ Time Frame: 1 year ]
Related Studies
- Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBDNot Yet Recruiting · Cook Children's Health Care System · Arlington, Texas
- Evaluation of the SMART IBD App in Pediatric IBDRecruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio
- Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBDRecruiting · Connecticut Children's Medical Center · Hartford, Connecticut